1Y returns
+14.84%
cat 12.11%3Y CAGR
—
cat 22.73%5Y CAGR
—
cat 13.72%Std deviation 3Y
—
cat 16.29%In plain English
BAJAJ FINSERV HEALTHCARE FUND is a Sectoral / Thematic scheme from Bajaj Finserv. The portfolio is ~96% in equities. Worst historical drawdown: -16% in Feb 2025, recovered in 9 months. Wrong fit if you need this money in less than 7 years.
Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.
NAV history
Showing Direct · Growth · INF0QA701AB9
NAV (Direct-Growth)
₹11.3030
Last 1Y
+15.44%
Drawdown stories
The crashes you should know about — and how long the fund took to recover.
Feb 2025
-15.7%Peak ₹10.13 on 2 Jan 2025 → trough ₹8.54 on 28 Feb 2025 (2 months down).
Mar 2026
-10.1%Peak ₹10.18 on 17 Nov 2025 → trough ₹9.15 on 23 Mar 2026 (4 months down).
Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.
Honesty score
A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.
Honesty score
4 / 5
Solid scheme on the dimensions we check. No red flags.
Expense ratio
0.66% — typical for category.
AUM size
₹333 Cr.
Sector concentration
Top 3 sectors = 94.3% — heavy concentration risk.
Performance
Returns for various periods, with category average and peer rank.
Portfolio composition
Asset allocation
- Equity95.79%
- Debt0.20%
- Cash4.00%
- Other0.01%
By market cap
- Large cap31.27%
- Mid cap22.61%
- Small cap32.52%
- Others13.60%
Concentration
Holdings
36
Avg market cap
₹50.4K Cr
Top 10 stocks
57.04%
Top 5 stocks
35.01%
Top 3 sectors
94.28%
Top holdings
Top 15 positions by weight, latest disclosure.
- 1—9.41%
Sun Pharmaceuticals Industries Ltd
- 1—9.07%
Divi's Laboratories Ltd
- 2—8.95%
Divi's Laboratories Ltd
- 3—6.75%
Apollo Hospitals Enterprise Ltd
- 2—6.73%
Apollo Hospitals Enterprise Ltd
- 4—6.63%
Aurobindo Pharma Ltd
- 3—6.54%
Sun Pharmaceuticals Industries Ltd
- 4—6.51%
Piramal Pharma Ltd
- 5—6.17%
Aurobindo Pharma Ltd
- 5—5.69%
Piramal Pharma Ltd
- 6—5.57%
Torrent Pharmaceuticals Ltd
- 6—5.26%
Torrent Pharmaceuticals Ltd
- 7—4.52%
Rubicon Research Ltd
- 8—4.39%
Neuland Laboratories Ltd
- 7—4.35%
Emcure Pharmaceuticals Ltd
Fundamentals (vs category)
Portfolio-weighted ratios, compared with the category average.
- P/E ratio45.3741.09+4.28
- P/B ratio5.885.83+0.05
- Price / Sales5.215.71-0.50
- Price / Cash Flow29.8830.54-0.66
- Dividend yield0.42%0.63%-0.21
- Return on equity (ROE)16.31%16.57%-0.26
Risk metrics
Standard deviation, Sharpe, Sortino, Beta — all vs category average.
- ———14.9216.2915.44
Standard deviation
Volatility — lower means steadier returns.
- 0.57——0.480.980.58
Sharpe ratio
Risk-adjusted return — higher is better.
- 0.99——0.831.710.94
Sortino ratio
Like Sharpe but only counts downside volatility.
- 0.94——0.940.950.94
Beta
1 = moves with the market. <1 = less volatile.
Peers in Sectoral / Thematic
Other schemes in the same SEBI category, ranked by AUM.
- ₹36.5K Cr+6.58%+22.72%0.57%
ICICI Prudential India Opportunities Fund
ICICI Prudential
- ₹36.5K Cr+1.48%+18.90%0.57%
ICICI Prudential India Opportunities Fund
ICICI Prudential
- ₹15.8K Cr+6.72%+21.95%0.64%
ICICI Prudential Business Cycle Fund Direct Plan Growth
ICICI Prudential
- ₹15.8K Cr+2.38%+18.99%0.64%
ICICI Prudential Business Cycle Fund Direct Plan Growth
ICICI Prudential
- ₹13.4K Cr-10.00%+10.76%0.86%
ICICI Prudential Technology Fund
ICICI Prudential
- ₹13.4K Cr-21.09%+5.76%0.86%
ICICI Prudential Technology Fund
ICICI Prudential
- ₹10.6K Cr+1.41%+13.88%0.87%
ICICI Prudential Banking and Financial Services Fund
ICICI Prudential
- ₹10.6K Cr-1.94%+11.58%0.87%
ICICI Prudential Banking and Financial Services Fund
ICICI Prudential
Available plans & options
Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.
NEW
See your SIP through Indian market history
Pick a fund and a start year — get a 60-second cinematic replay of every crash, boom, and headline with your money in it. Real NAV data, no “assumed 12%” lies.
Try Wealth Time MachineAI · Free
Find what's really inside your funds
Upload your CAS PDF — get instant stock concentration, hidden fund overlap, sector risk, and 3 specific actions, written by AI in plain English.
Run Portfolio X-Ray